Korea Pharmaceutical Manufacturers Association President Under Fire For Alleged Kickbacks
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Four months after an aggressive declaration that his association would not tolerate any member company involvement in unethical or improper business deals with doctors and hospitals, the president of the Korea Pharmaceutical Manufacturers Association is under fire for his company's alleged kickbacks to doctors
You may also be interested in...
Korean Health Ministry Seeks Prescriptions Listing Active Pharmaceutical Ingredients: Bad News For Brand Name Drugs
SEOUL - South Korea's Ministry of Health, Welfare and Family Affairs is currently mulling plans to require doctors writing prescriptions to include the drug's generic name and active ingredients
Korean Health Ministry Seeks Prescriptions Listing Active Pharmaceutical Ingredients: Bad News For Brand Name Drugs
SEOUL - South Korea's Ministry of Health, Welfare and Family Affairs is currently mulling plans to require doctors writing prescriptions to include the drug's generic name and active ingredients
Korea Moving To Sue 104 Drug Firms, Including Some MNCs, For Selling Substandard Generics
Bioequivalence tests are conducted to compare generic versions of medicines with the originals to ascertain whether or not they are equal. These tests are especially important in South Korea, where generic drugs are the main profit drivers for many local pharmaceutical producers.